Ingredient In Cough Medicine Effectively Treats Prostate Cancer

[Guest guest]

This laboratory study was a joint effort by Dr. Israel Barken of the

Prostate Cancer Research and Educational Foundation, Moshe Rogosnitzky

of MedInsight Research Institute, and Dr. Jack Geller of UC San Diego. Noscapine has previously been studied as a

treatment for breast, ovarian, colon, lung and brain cancer and for

various lymphomas, chronic lymphocytic leukemia and melanoma. This

study, however, is the first to demonstrate its effectiveness in

treating prostate cancer.

Noscapine is a naturally-occurring substance, a non-addictive

derivative of opium. As a natural substance, noscapine cannot be

patented, which has limited the potential for clinical trials.

Rogosnitzky notes that drug companies are generally unwilling to

underwrite expensive clinical trials without being able to recoup their

investment. A synthetic derivative of noscapine has been patented but

has not yet reached the clinical testing phase.

Click on the below link for the full story:<http://www.medicalnewstoday.com/articles/133891.php>